NEW YORK ( TheStreet) -- Shares of ADVENTRX Pharmaceuticals (AMEX: ANX) were gapping down Monday morning with an open price 11.4% lower than Friday's closing price. The stock closed at $2.46 Friday and opened today's trading at $2.18. The average volume for ADVENTRX has been one million shares per day over the past 30 days. ADVENTRX has a market cap of $66.2 million and is part of the health care sector and drugs industry. Shares are down 5.7% year to date as of the close of trading on Friday. ADVENTRX Pharmaceuticals, Inc., specialty pharmaceutical company, focuses on acquiring, developing, and commercializing proprietary product candidates. Its lead products include Exelbine or ANX-530, an emulsion formulation of the chemotherapy drug vinorelbine. TheStreet Ratings rates ADVENTRX as a sell. The company's weaknesses can be seen in multiple areas, such as its unimpressive growth in net income and poor profit margins. You can view the full ADVENTRX Ratings Report. Get more investment ideas from our investment research center. Interested in other stocks that are gapping down? Get free SMS text alerts sent to you when the action happens by texting DOWN to 95370 or select from multiple alert options.
Shares of ADVENTRX Pharmaceuticals (AMEX:ANX) were gapping down Friday morning with an open price 21.5% lower than Thursday's closing price. The stock closed at 93 cents yesterday and opened today's trading at 73 cents.